Driehaus Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-32,122
Closed -$2.98M 621
2014
Q4
$2.98M Buy
32,122
+16,436
+105% +$1.53M 0.12% 229
2014
Q3
$1.08M Sell
15,686
-16,512
-51% -$1.14M 0.04% 418
2014
Q2
$3.37M Buy
32,198
+7,806
+32% +$818K 0.11% 248
2014
Q1
$2.02M Buy
+24,392
New +$2.02M 0.06% 331
2013
Q4
Sell
-25,060
Closed -$1.59M 579
2013
Q3
$1.59M Sell
25,060
-123,351
-83% -$7.82M 0.06% 299
2013
Q2
$6.23M Buy
+148,411
New +$6.23M 0.27% 119